Full Circles Therapeutics Patents

Patent portfolio assigned to Full Circles Therapeutics (verified via public assignee records). Estimated patent count: 1. Full Circles Therapeutics (formerly Stellate Biotherapeutics; CDL). Non-viral genome engineering (GATALYST / circular single-stranded DNA) for genetic disease, autoimmune disease and cancer. Patent confirmed via CB Insights (1 granted: 'Targeted genome modification using circular single-stranded DNA'). Novo Nordisk sponsored the Pathbreaker Award it received (relationship: collaboration/partner). No direct competitors confirmed from a fetched page.